儿童影像检查中静脉对比剂的安全性考量
本文综述了儿童使用静脉对比剂(MRI、CT、US)的不良事件频率与类型。总体而言,儿童静脉对比剂安全性很高,但需熟悉如何治疗和预防罕见不良事件,并了解钆沉积问题以协助沟通。
要点
- 儿童静脉对比剂总体安全性高,严重不良事件罕见。
- 需掌握罕见不良事件的预防与处理方法以避免不良结局。
- 了解钆沉积有助于与临床医生和家长沟通。
核心结论
- 儿童静脉对比剂总体非常安全,但需熟悉罕见不良事件的防治并了解钆沉积以优化沟通。
研究设计与样本
- 本文为综述,汇总儿童文献中静脉对比剂相关不良事件的频率与类型,涵盖MRI、CT和US。
临床应用与阅片要点
- 日常阅片及报告时无需因对比剂安全性而回避必要的增强检查,但应知晓不良事件防治流程。
- 与临床医生和家长沟通时,可引用本综述关于儿童对比剂安全性的总体结论及钆沉积知识。
局限性
- 为综述性文章,未提供原始研究的具体样本量、中心数或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Intravenous contrast media are used in MRI, CT and US studies for anatomical evaluation and lesion characterization. Safety is always of paramount importance when administering any contrast media to children, and it is important for radiologists and ordering providers to be knowledgeable of the safety profiles and potential adverse events that can occur. This manuscript reviews the frequency and types of adverse events associated with intravenous contrast agents reported in the pediatric literature. Overall, intravenous contrast agents are very safe to use in children. However, familiarity with how to treat and prevent these uncommon events is crucial in preventing poor outcomes. In addition, an understanding of gadolinium deposition in tissues can help facilitate conversations with concerned physicians and parents. This review provides a concise yet comprehensive reference for radiologists and ordering providers on intravenous contrast safety considerations in the pediatric patient.
引用
- Cheeney, Maloney, Iyer, et al. Safety considerations related to intravenous contrast agents in pediatric imaging. Pediatr Radiol. 2022. PMID: 35941280. doi:10.1007/s00247-022-05470-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。